Literature DB >> 7901531

Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C.

J Y Lau1, M Mizokami, T Ohno, D A Diamond, J Kniffen, G L Davis.   

Abstract

Serial serum samples and pretreatment and post-treatment liver tissue from patients with chronic hepatitis C virus (HCV) infection were tested for HCV RNA by reverse-transcription polymerase chain reaction and branched DNA signal amplification assays. At the end of treatment with interferon-alpha (IFN alpha), 4 of 5 patients showing no biochemical response (in alanine aminotransferase activity), 4 of 5 with transient responses, and 1 of 5 showing complete and sustained responses had HCV RNA detectable in serum. The corresponding numbers for liver tissue were 5, 5, and 0 (of 4). However, all 5 complete responders had virological relapses within 6 months. Biochemical response may not reflect virological profile during IFN alpha treatment of HCV.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901531     DOI: 10.1016/0140-6736(93)92187-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

Review 1.  Quantitative molecular analysis of virus expression and replication.

Authors:  M Clementi
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Gary L. Davis, MD: a conversation with the editor. Interview by William Clifford Roberts.

Authors:  Gary L Davis
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-01

3.  Preferential virological response to interferon-alpha 2a in patients with chronic hepatitis C infected by virus genotype 3a and exhibiting a low gamma-GT/ALT ratio.

Authors:  S Mihm; H Hartmann; A Fayyazi; G Ramadori
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 4.  Hepatitis C: diagnosis and treatment.

Authors:  I Scotiniotis; C A Brass; P F Malet
Journal:  J Gen Intern Med       Date:  1995-05       Impact factor: 5.128

Review 5.  Histopathology and detection of hepatitis C virus in liver.

Authors:  P J Scheuer; K Krawczynski; A P Dhillon
Journal:  Springer Semin Immunopathol       Date:  1997

6.  Sustained viral response is rarely achieved in patients with high viral load of HCV RNA by excessive interferon therapy.

Authors:  Y Shiratori; N Kato; H Yoshida; R Nakata; M Ihori; F Imazeki; O Yokosuka; T Kawase; T Katamoto; T Unuma; A Nakamura; F Ikegami; K Hirota; M Omata
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

Review 7.  Quantitative molecular methods in virology.

Authors:  M Clementi; S Menzo; A Manzin; P Bagnarelli
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis.

Authors:  H Senturk; O Uzunalimoglu; Y Batur; I Simsek; A Mert; G Ozbay; H Cetinkaya; G Ersoz; F Tabak; H Akbaylar; M Akdogan; A Dokmeci; A Sonsuz; S Ozenirler; E Erden; N Tozum
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

Review 9.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

10.  Preclinical evaluation of AMPLICOR hepatitis C virus test for detection of hepatitis C virus RNA.

Authors:  F S Nolte; C Thurmond; M W Fried
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.